Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine vs Observation Following Surgery for Biliary Tract Cancer
NCT00363584Phase 3Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Mar 2006
- Primary completion
- Aug 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in biliary tract cancer (BTC), sponsored by University Hospital Southampton NHS Foundation Trust. Started Mar 2006; status: completed.
02
Drugs
capecitabine
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00363584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363584.